Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to ...

Ultragenyx Pharmaceutical RARE reported new findings from an ongoing, pivotal study of its investigational ... Rare Pediatric Disease and Orphan Drug designations in the United States.

It can occur with prescription or nonprescription drugs. It can also range from mild to severe. Substance use disorder, formerly known as “drug abuse,” develops when substance use interferes ...

The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease. This decision is based on strong efficacy data from ...

Next in the study, published in the journal Drug and Alcohol Dependence, were stimulants such as Adderall, Ritalin, and methamphetamine, with an average of 4.4 quit attempts, followed by alcohol ...

ITM-11, the drug that ITM says succeeded in the Phase 3 neuroendocrine cancer study, contains the isotope lutetium-177, which is packaged together with a compound that targets a protein known as the ...

Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...

The company also did not disclose safety data from the study. "We believe weight loss of the combined drugs and safety are (the) key metrics investors are looking for," Truist Securities analyst ...

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...

SALT LAKE CITY — Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...

It’s time to move on from treating heroin as Europe’s main drug problem, according to the head of the European Union’s drugs agency. That’s not to say heroin isn’t still a major problem.